0001062993-14-006901.txt : 20141125
0001062993-14-006901.hdr.sgml : 20141125
20141125162756
ACCESSION NUMBER: 0001062993-14-006901
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20141124
FILED AS OF DATE: 20141125
DATE AS OF CHANGE: 20141125
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOSPECIFICS TECHNOLOGIES CORP
CENTRAL INDEX KEY: 0000875622
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 113054851
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 35 WILBUR ST
CITY: LYNBROOK
STATE: NY
ZIP: 11563
BUSINESS PHONE: 5165937000
MAIL ADDRESS:
STREET 1: 35 WILBUR STREET
CITY: LYNBROOK
STATE: NY
ZIP: 11563
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Schamroth Michael
CENTRAL INDEX KEY: 0001375385
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34236
FILM NUMBER: 141249955
MAIL ADDRESS:
STREET 1: 191 MEADOWVIEW AVENUE
CITY: HEWLETT
STATE: NY
ZIP: 11557
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0306
4
2014-11-24
0000875622
BIOSPECIFICS TECHNOLOGIES CORP
BSTC
0001375385
Schamroth Michael
C/O BIOSPECIFICS TECHNOLOGIES CORP.
35 WILBUR STREET
LYNBROOK
NY
11563
1
0
0
0
Common Stock, $0.001 par value
2014-11-24
4
S
0
4499
39.3560
D
30000
D
The selling price of $39.3560 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $39.20 to $39.50. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
/s/ Michael Schamroth by Carl A. Valenstein, attorney-in-fact
2014-11-25